The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDuke Capital Regulatory News (DUKE)

Share Price Information for Duke Capital (DUKE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 32.75
Bid: 32.50
Ask: 33.00
Change: 0.25 (0.76%)
Spread: 0.50 (1.538%)
Open: 32.75
High: 33.50
Low: 33.00
Prev. Close: 32.75
DUKE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

New Royalty Agreement

2 Aug 2021 07:00

RNS Number : 1582H
Duke Royalty Limited
02 August 2021
 

2 August 2021

 

Duke Royalty Limited

 

("Duke Royalty" or "Duke")

 

New Royalty Agreement with Engineering, Procurement and Construction Services Business

 

Duke Royalty, a provider of alternative capital solutions to a diversified range of profitable and long-established businesses in Europe and abroad, is pleased to announce that it has further broadened its revenue base by entering into an CA$8.3 million (approximately £4.8 million) royalty financing agreement (the "Financing") with Creō-Tech Industrial Group Inc. ("Creō-Tech").

 

Creō-Tech is a Canadian holding company that has been set up to acquire businesses that provide engineering, procurement and construction ("EPC") services in commercial and industrial settings. In connection with the Financing, Creō-Tech has acquired two businesses, Axial Inc. ("Axial" and together with its subsidiaries "Axial Group") and Silhouette Enclosures Ltd. ("Silhouette"). Axial is a provider of industrial automation and engineering services based in Calgary, Alberta, and Silhouette specialises in the design and fabrication of custom industrial enclosures and is based in Abbotsford, British Columbia.

 

Highlights:

 

· Duke has agreed a total funding commitment of up to CA$20 million (approximately £11.6 million) to support Creō-Tech's buy-and-build strategy to acquire profitable EPC businesses across Canada

· CA$8.3 million initial drawdown to facilitate the acquisitions of Silhouette and Axial, both of which have a longstanding operations and predictable revenue streams

· Initial cash yield of 13.2% per annum via monthly payments, which commence immediately

· 30-year secured financing, with distributions to be adjusted annually to reflect Creō-Tech's consolidated revenue growth, on typical Duke terms

· As part of the financing, Duke will take an initial 18.75% equity stake in Creō-Tech.

 

Neil Johnson, CEO of Duke Royalty, said:

 

"Since our successful fundraise in April, Duke Royalty has entered into three new partnerships, building on the record normalised cash revenue that we recently reported for the first quarter of our current financial year. This partnership is also Duke's first significant deal in North America, diversifying our geographic presence, as well as our revenue base. Duke's investment in Creō-Tech is consistent with our investment strategy in that it supports a buy-and-build model focused on the acquisition of long standing, profitable companies in an attractive and fragmented market with potential for additional follow-on investments.

 

"Duke is backing a strong management team in Creō-Tech. With significant industry experience they will look to identify and acquire profitable, private businesses, whilst driving growth and profitability across the group by realising synergies and pooling back-end functions."

 

Dirk Maritz, CEO of Creō-Tech, said:

 

"Duke's investment solution is a great fit for the Creō-Tech group of companies. It has provided a platform for Creō-Tech's growth both organically and through future acquisitions. We are excited to be partnered with Duke to execute on our clearly defined plan to create a multi-disciplinary, high quality EPC firm."

 

Further information regarding Creō-Tech:

 

Creō-Tech is a privately-owned group of companies offering innovative multi-disciplinary engineering & manufacturing applications in energy, power generation, material handling, mining, manufacturing & processing, telecommunications and utilities markets. In addition to its reputable manufacturing operation, Creō-Tech offers a full complement of services to the North American industrial mid-market, including structural, electro-mechanical, automation and technical support solutions. Creō-Tech offers a competitive advantage through customised approaches and innovative solutions, to meet client's needs. To learn more, visit creotechgroup.com.

 

Axial Group

 

Axial Group is a boutique, multi-disciplinary engineering firm offering clients EPC services in a wide variety of industries. Established in Calgary, Alberta in 1997, Axial Group has comprehensive industry expertise and technological capabilities, delivering innovative structural and electro-mechanical engineering, industrial automation and industrial IT solutions, in both new construction and retrofit environments. Axial Group has extensive global expertise, having delivered and managed projects both domestically and internationally.

 

Silhouette

 

Silhouette is a specialised leader in custom design and fabrication of industrial enclosures and control rooms. Silhouette, located near Vancouver, Canada with an 18-year history, works directly with its clients to customize structural and electro-mechanical designs, develop innovative acoustic and vibration solutions, and manufacture high-quality products. The company supplies products worldwide, with a primary focus in the Telecommunications, Utilities, Marine & Port, Material Handling, and customers in harsh or remote environments.

 

About the Financing

 

Duke has provided an initial investment of CA$8.3 million to finance Creō-Tech's first two acquisitions, Axial Group and Silhouette, with a total potential investment of up to CA$20.0 million to fund future acquisitions. As part of the financing, Duke will take an initial 18.75% equity stake in Creō-Tech. Future tranches of capital are planned at Duke's sole discretion.

 

The terms of the Financing are in line with Duke's typical investment criteria. The Financing is provided through a combination of a secured loan and preference shares and Duke will be entitled to monthly distributions (the "Distribution") beginning in August 2021.

 

In line with Duke's other investments, and reflective of the participating nature of Duke's business model, the Distribution will be adjusted annually based on the percentage change in Creō-Tech's total combined gross revenues for the 12 months to 31 December 2022, compared to the prior financial (calendar) year. The first adjustment will occur from 1 January 2023. The annual adjustment in the Distribution will be subject to an agreed collar, in line with Duke's typical terms.

 

The Financing is for a period of 30 years, with the Distribution payable to Duke throughout the duration of this term, unless Creō-Tech utilises an early buyback option which will trigger an early redemption payment to Duke.

 

 

Duke Royalty Portfolio

 

A full list of Duke's current Royalty Partners are now included for reference on our Partners page of our website: www.dukeroyalty.com/partners

 

This announcement contains inside information.

 

***ENDS***

 

 

For further information, please visit www.dukeroyalty.com or contact:

 

Duke Royalty Limited

Neil Johnson / Charlie Cannon Brookes / Hugo Evans

 

+44 (0) 1481 730 613

Cenkos Securities plc 

(Nominated Adviser

and Joint Broker)

Stephen Keys / Callum Davidson / Julian Morse / Michael Johnson

+44 (0) 207 397 8900

 

 

 

Canaccord Genuity

(Joint Broker)

 

Adam James / Georgina McCooke

+44 (0) 207 523 8000

SEC Newgate (PR)

Elisabeth Cowell / Richard Bicknell / Megan Kovach

+ +44 (0) 20 3757 6880 dukeroyalty@secnewgate.co.uk

 

About Duke Royalty

 

Duke Royalty Limited provides alternative capital solutions to a diversified range of profitable and long-established businesses in Europe and abroad. Duke Royalty's experienced team provide financing solutions to private companies that are in need of capital but whose owners wish to maintain equity control of their business. Duke Royalty's royalty investments are intended to provide robust, stable, long term returns to its shareholders. Duke Royalty is listed on the AIM market under the ticker DUKE and is headquartered in Guernsey.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CNTUAOBRANUWRAR
Date   Source Headline
22nd Jun 20173:19 pmRNSFinal Results and Maiden Dividend
22nd Jun 20177:00 amRNSFinal Results
9th Jun 20177:00 amRNSRoyalty Partner Operational Update
6th Apr 20177:00 amRNSInaugural royalty financing agreement
28th Mar 20177:00 amRNSHolding(s) in Company
24th Mar 20172:55 pmRNSHolding(s) in Company
23rd Mar 20175:00 pmRNSRe-Admission and First Day of Dealings
22nd Mar 20173:45 pmRNSSch 1 Update - Duke Royalty Limited
20th Mar 20179:35 amRNSSch 1 Update - Duke Royalty Limited
17th Mar 20176:17 pmRNSResult of Fundraising
16th Mar 20175:03 pmRNSProposed Placing and Subscription
21st Feb 201711:25 amRNSSch 1 Update - Duke Royalty Limited
1st Feb 201711:00 amRNSSchedule 1 - Duke Royalty Limited
11th Jan 20177:01 amRNSAppointment of Chief Investment Officer
11th Jan 20177:00 amRNSChange of Advisors and Operational Update
17th Nov 20169:00 amRNSUnaudited interim results
1st Sep 201612:02 pmRNSResult of AGM
25th Jul 20167:00 amRNSFinal Results
29th Mar 20161:32 pmRNSSale of investments
7th Mar 20167:00 amRNSBoard Changes and Corporate Update
3rd Feb 20167:00 amRNSDirector/PDMR Shareholding
19th Jan 20169:55 amRNSChange of Adviser
14th Dec 201511:40 amRNSDirector/PDMR Shareholding
23rd Nov 20157:00 amRNSInterim results
29th Oct 20157:00 amRNSHolding(s) in Company
29th Oct 20157:00 amRNSCorrection: Appointment and Issue of Shares
28th Oct 20157:00 amRNSMr Justin Cochrane Appointment and Issue of Shares
12th Oct 20155:16 pmRNSHolding(s) in Company
17th Sep 20153:40 pmRNSFormation of Healthcare Investment Committee
14th Sep 201512:41 pmRNSHolding(s) in Company
11th Sep 20157:00 amRNSDirector share purchase
10th Sep 201512:00 pmRNSResult of AGM
7th Sep 20159:15 amRNSGrant of options
7th Sep 20157:00 amRNSPlacing
7th Sep 20157:00 amRNSCollaboration with Oliver Wyman
4th Aug 201512:21 pmRNSChanges to NAV Reporting
27th Jul 20154:12 pmRNSResults for the year ended 31 March 2015
16th Jun 201511:36 amRNSResult of EGM
10th Jun 201511:21 amRNSHolding(s) in Company
2nd Jun 20151:57 pmRNSHolding(s) in Company
28th May 201511:00 amRNSEGM, proposed changes to board & investing policy
26th May 20159:58 amRNSHolding(s) in Company
26th May 20159:57 amRNSHolding(s) in Company
26th May 20159:56 amRNSHolding(s) in Company
26th May 20159:56 amRNSHolding(s) in Company
22nd May 20155:15 pmRNSRepayment of zero dividend preference shares
20th May 20157:00 amRNSPlacing
15th May 201511:08 amRNSSale of investment
20th Apr 20155:36 pmRNSNet Asset Value(s)
19th Jan 20154:27 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.